Quarterly Earnings

Amid a truck market slump, Core Molding Technologies reveals a strategic shift, leveraging new ventures in energy storage and a major expansion in Mexico.

HSBC Continental Europe's profits fell 88% after a €300M loss on its Malta sale, but a closer look reveals a deliberate pivot toward a leaner future.

TPG reports record first-half results, beating Q2 revenue and EPS estimates. The firm's diversified model and strong AUM growth signal robust health.

Beneath stellar 38% revenue growth, Amex GBT's Q2 results reveal a strategy fueled by AI innovation, key client wins, and an impending private equity era.

As Tecan prepares to unveil its H1 2026 results, the numbers will offer more than a corporate health check—they are a key signal for the entire lab automation industry's recovery.

NexPoint Residential's latest earnings show industry-wide strains, but a new high-yield lending program reveals a savvy strategy to navigate the turbulence.

Shoals Technologies posts a 47% revenue surge and a record $801M backlog, yet shrinking profits reveal the immense operational friction of wiring the energy transition.

Westlake Chemical Partners reports flat net income but a massive cash flow jump, proving its post-turnaround efficiency and fortifying its reputation for stability.

A deep dive into Westlake's stunning Q2 turnaround, where a $600M strategic plan met global supply shocks, creating a powerful recovery amid market chaos.

Enpro's Q2 results reveal a powerful strategy: leveraging the AI-driven semiconductor boom to deliver record growth while navigating a mixed industrial landscape.

A 22% AFFO surge and record RevPAR aren't luck. Inside Chatham Lodging's Q2 success driven by strategic buys and relentless operational efficiency.

As Organigram preps its Q3 results, all eyes are on its German expansion and its ability to defend its top spot in the competitive Canadian market.

Strong Q2 results, pivotal deals with AstraZeneca and MSK, and a clear path to profitability signal SOPHiA GENETICS is converting its AI platform into market leadership.

Behind Cat Financial's record quarter lies a story of surging global demand, shrewd risk management, and the hidden engine driving the world's heavy machinery.

A massive legal settlement pushed Otter Tail to a quarterly loss, yet a closer look at the numbers shows a company shedding risk and flexing its muscles.

IIP's Q2 results show a REIT in transition. While actively managing tenant defaults in its core cannabis portfolio, a major $270M bet on life sciences begins to pay off.

With upcoming earnings and a key conference, AirSculpt aims to prove its recent turnaround is real. We analyze the signals beyond the numbers.

UFP Technologies posts record profits, but the real story is its strategic pivot—investing heavily in nearshoring and leadership to dominate MedTech's future.

Fresh off a quarter of explosive growth, pawn giant EZCORP is hitting the road. We look at the strategy behind the numbers and what it means for the future.

GBDC posts a return to profitability and maintains its dividend, but a closer look reveals strategic capital moves amid subtle shifts in portfolio health.